These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 6585175

  • 1. Hyperlipidemia in acute lymphoblastic leukemia.
    Blackett PR, Koren E, Blackstock R, Downs D, Wang CS.
    Ann Clin Lab Sci; 1984; 14(2):123-9. PubMed ID: 6585175
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
    Schreier L, Berg G, Zago V, Gonzalez AI, Wikinski R.
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
    [Abstract] [Full Text] [Related]

  • 3. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C, Lisch HJ, Drexel H, Braunsteiner H.
    Schweiz Med Wochenschr; 1983 Jun 25; 113(25):909-13. PubMed ID: 6612272
    [Abstract] [Full Text] [Related]

  • 4. Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes.
    Takeda R, Tatami R, Ueda K, Haba T, Kawato M, Nakabayashi H, Mabuchi H.
    Endokrinologie; 1982 Feb 25; 79(1):140-8. PubMed ID: 7084127
    [Abstract] [Full Text] [Related]

  • 5. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.
    Weinstock PH, Bisgaier CL, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL.
    J Clin Invest; 1995 Dec 25; 96(6):2555-68. PubMed ID: 8675619
    [Abstract] [Full Text] [Related]

  • 6. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Nov 15; 98(10):2259-67. PubMed ID: 8941642
    [Abstract] [Full Text] [Related]

  • 7. The influence of apoprotein epsilon 2 homozygosity on nephrotic hyperlipidemia.
    Joven J, Vilella E.
    Clin Nephrol; 1997 Sep 15; 48(3):141-5. PubMed ID: 9342484
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 9. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K, Kiessling H.
    Artery; 1981 Aug 26; 9(6):456-76. PubMed ID: 7337554
    [Abstract] [Full Text] [Related]

  • 10. [On the etiology of diabetic hyperlipidemia from the aspects of the metabolism of ApoHDL (author's transl)].
    Keimatsu M.
    Hokkaido Igaku Zasshi; 1981 Sep 26; 56(5):557-69. PubMed ID: 7319464
    [Abstract] [Full Text] [Related]

  • 11. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS, Chait A, Hazzard WR.
    J Lab Clin Med; 1982 Jan 26; 99(1):15-24. PubMed ID: 6948063
    [Abstract] [Full Text] [Related]

  • 12. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T, Liang J, Wang X, Ichikawa T, Shiomi M, Sun H, Watanabe T, Liu G, Fan J.
    Cardiovasc Res; 2005 Feb 01; 65(2):524-34. PubMed ID: 15639492
    [Abstract] [Full Text] [Related]

  • 13. A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis.
    Nakagawa M, Kimura S, Fujimoto K, Atumi H, Imura J, Chikazawa Y, Imamura H, Okuyama H, Yamaya H, Fukushima T, Nakagawa A, Asaka M, Yokoyama H.
    Ther Apher Dial; 2008 Dec 01; 12(6):509-13. PubMed ID: 19140851
    [Abstract] [Full Text] [Related]

  • 14. [Studies on the heredity and pathogenesis of familial combined hyperlipidemia ("multiple lipoprotein type" hyperlipidemia)].
    Stähelin HB, Buchmann P, Strub P, Göschke H, Thiel G, Koller F.
    Schweiz Med Wochenschr; 1976 Sep 25; 106(39):1301-12. PubMed ID: 1006248
    [Abstract] [Full Text] [Related]

  • 15. Mechanism(s) of hyperlipidemia in chronic uremia.
    Bagdade JD, Shafrir E, Wilson DE.
    Trans Am Soc Artif Intern Organs; 1976 Sep 25; 22():42-5. PubMed ID: 181888
    [No Abstract] [Full Text] [Related]

  • 16. [Hyperlipidemia in obesity].
    Nishino M, Katsukawa F, Kataoka K.
    Nihon Rinsho; 1990 Nov 25; 48(11):2572-7. PubMed ID: 2270023
    [No Abstract] [Full Text] [Related]

  • 17. [Residual dyslipoproteinemias after ethanol-weaning in alcoholic hyperlipidemic patients (author's transl)].
    Buxtorf JC, Martin O.
    Pathol Biol (Paris); 1977 Feb 25; 25(2):109-12. PubMed ID: 191780
    [Abstract] [Full Text] [Related]

  • 18. [Lipoprotein lipase, diabetes mellitus and hypertriglyceridemia].
    Goldsztajn P.
    Przegl Lek; 1988 Feb 25; 45(11):787-92. PubMed ID: 3072592
    [No Abstract] [Full Text] [Related]

  • 19. Substrate incorporation into lipids and proteins in human liver slices. An experimental study with special reference to dyslipoproteinemic conditions.
    Stakeberg H.
    Acta Med Scand Suppl; 1974 Feb 25; 561():1-30. PubMed ID: 4376888
    [No Abstract] [Full Text] [Related]

  • 20. [Role of lipolytic enzymes in the development of hyperlipidemia induced by administration of heterologous albumin in rabbits].
    Serrano DS, Nikul'cheva NG, Soliternova IB.
    Biull Eksp Biol Med; 1984 Jan 25; 97(1):42-5. PubMed ID: 6692022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.